Sharon L. Wienbar net worth and biography

Sharon Wienbar Biography and Net Worth

Director of Enovis

Sharon Wienbar has served as a director of the Company since June 15, 2016, assuming the position of Chair in May 2025. She was previously with Scale Venture Partners, a venture capital firm, from 2001 to 2018, where she led investments in technology companies and served on the board of numerous portfolio businesses. She was also a strategy consultant to Capella Education Company after it acquired Hackbright Academy, a leading software engineering training company for women, where she was the CEO from 2015 to 2016. Sharon currently serves on the boards of Resideo Technology (NYSE: REZI), Ingram Micro, an information technology leader (NYSE: INGM), True Anthem, a privately held software provider, and Kaleido Health, a leading women’s health app. She previously served on other public and private boards, including Covetrus, Inc., a Nasdaq listed public company, until its acquisition in October 2022, the board of Everyday Health, Inc., a NYSE-listed public company, until its acquisition in December 2016. Prior to her venture capital career, Sharon was an executive in several software companies and a consultant at Bain & Company. Sharon’s leadership of technology investments, deep understanding of innovation drivers, and business acumen bring an important perspective to our Board. Sharon serves as a member of the Compensation and Human Capital Management Committee of the Board.

What is Sharon L. Wienbar's net worth?: The estimated net worth of Sharon L. Wienbar is at least $1.23 million as of November 10th, 2026. Ms. Wienbar owns 44,651 shares of Enovis stock worth more than $1,233,662 as of November 13th. This net worth evaluation does not reflect any other investments that Ms. Wienbar may own. Learn More about Sharon L. Wienbar's net worth.
How do I contact Sharon L. Wienbar?: The corporate mailing address for Ms. Wienbar and other Enovis executives is 2900 Lake Vista Drive, Suite 200, Lewisville, TX, 75067. Enovis can also be reached via phone at 302-252-9160 and via email at [email protected]. Learn More on Sharon L. Wienbar's contact information.
Has Sharon L. Wienbar been buying or selling shares of Enovis?: During the past quarter, Sharon L. Wienbar has bought $99,749.19 in Enovis stock. Most recently, on Wednesday, November 11th, Sharon L. Wienbar bought 900 shares of Enovis stock. The stock was acquired at an average cost of $27.76 per share, with a total value of $24,984.00. Following the completion of the transaction, the director now directly owns 45,551 shares of the company's stock, valued at $1,264,495.76. Learn More on Sharon L. Wienbar's trading history.
Who are Enovis' active insiders?: Enovis' insider roster includes Benjamin Berry (CFO), Oliver Engert (Insider), Christopher Hix (CFO), John Kleckner (Insider), Patricia Lang (SVP), Damien Mcdonald (CEO), A. Perfall (Director), Daniel Pryor (EVP), Brady Shirley (COO), Bradley Tandy (SVP), Matthew Trerotola (CEO & Chairman), Rajiv Vinnakota (Director), and Sharon Wienbar (Director). Learn More on Enovis' active insiders.
Are insiders buying or selling shares of Enovis?: During the last year, Enovis insiders bought shares 21 times. They purchased a total of 40,323 shares worth more than $888,437.22. During the last year, insiders at the sold shares 2 times. They sold a total of 1,665 shares worth more than $45,294.66. The most recent insider tranaction occured on November, 11th when Director Sharon L. Wienbar bought 900 shares worth more than $24,984.00. Insiders at Enovis own 2.9% of the company. Learn More about insider trades at Enovis.
Information on this page was last updated on 11/11/2026.

Sharon L. Wienbar Insider Trading History at Enovis

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/11/2026	Buy	900	$27.76	$24,984.00	45,551
11/10/2026	Buy	874	$28.43	$24,847.82	44,651
11/9/2026	Buy	924	$26.98	$24,929.52	43,777
11/6/2026	Buy	907	$27.55	$24,987.85	42,853

Sharon L. Wienbar Buying and Selling Activity at Enovis

Enovis Company Overview

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

Today's Range

Now: $27.63

$27.26

$28.68

50 Day Range

MA: $20.36

$17.44

$28.62

2 Week Range

Now: $27.63

$16.70

$31.81

Volume

1,153,270 shs

Average Volume

1,886,113 shs

Market Capitalization

$1.59 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.31